ArticleFrontiers in pharmacology2020

Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data.

Jingsong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.